Evidence map›Paper›PMID 41049858›Full record

ArticleFrontiers in oncology2025

Recurrence patterns and prognosis of esophageal cancer patients based on the Rbr resection status.

Peng Zhang, Guoqing Zhang, Kaishang Zhang, Yujin Qiao, Xiangnan Li, Song Zhao

Abstract read
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Peng Zhang *Department of Thoracic Surgery, First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Guoqing Zhang *Department of Thoracic Surgery, First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Kaishang ZhangDepartment of Thoracic Surgery, First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Yujin QiaoDepartment of Thoracic Surgery, First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Xiangnan LiDepartment of Thoracic Surgery, First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Song ZhaoDepartment of Thoracic Surgery, First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Despite achieving complete resection (R0) and pathological complete response (pCR) in esophageal squamous cell carcinoma (ESCC) patients, recurrence is still observed, resulting in poorer overall survival (OS). We introduced a resection status classification, Rbr Materials and methods: We retrospectively reviewed ESCC patients who underwent neoadjuvant therapy plus curative surgery in the Department of Thoracic Surgery at the First Affiliated Hospital of Zhengzhou University between April 2017 and August 2023. Overlap weighting (OW) was used to balance the baseline characteristics between Rbr Results: In total, 443 eligible patients were included and categorized into Rbr Conclusions: Rbr

Indexed as

esophageal squamous cell carcinomalocoregional recurrenceneoadjuvant therapyRbrrecurrence

Identifiers

PMID41049858
PMCPMC12491039

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.